Underneath the Lost Kilos: Imaging in Obesity and Metabolic Disease Drug Development

Time: 11:30 am
day: Day One

Details:

  • Imaging methodologies (e.g. DXA, MRI) provide information about different aspects of body composition meeting different needs in clinical trials
  • Body composition assessment of muscle and adipose tissue can be combined with measures of other end-organ effects for a deeper understanding of treatment responses
  • MRI-based methods can also provide detailed insights into muscle composition including inter- and intramuscular fat, glycogen, sodium and functional readouts

Speakers: